CAMBRIDGE, MA, Privately held medical device company developing the novel Touch Activated Phlebotomy (TAP) painless blood sampling system, closed the final tranche of a $10 million series-A financing with existing investors Flagship Ventures and Polaris Venture Partners.   
Read More